Macquarie Park, Australia · Founded 2022 · Privately Held (backing)
Developer of neurotherapeutic interventions designed for treatment-resistant neurodegenerative conditions. Celosia Therapeutics is based in Macquarie Park, Australia and was founded in 2022. It has raised $18.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$18.8M
Last round
—
Team — not yet on record
No current team members for Celosia Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Celosia Therapeutics with a free account
·Watch Celosia Therapeutics: the Monday email on marks, rounds and moves
